Eliminating hepatitis C transmission by enhancing hepatitis C care and treatment in primary health care settings.

在发达国家，注射吸毒者（PWID）是感染丙型肝炎（HCV）风险最高的人群，但很少有PWID接受HCV治疗。随着高效的非干扰素治疗的出现，HCV消除虽然雄心勃勃，但现在正在全球范围内认真考虑。这项伙伴关系赠款将探讨通过加强初级卫生保健环境中对PWID的HCV护理和治疗来消除HCV传播的可行性。

In developed countries, people who inject drugs (PWID) are the group at greatest risk of hepatitis C (HCV) infection but few PWID receive HCV treatment. With the advent of highly effective non-interferon based treatments HCV elimination, although ambitious, is now being seriously considered globally. This partnership grant will explore the feasibility of eliminating HCV transmission by enhancing HCV care and treatment for PWID in primary health care settings.